Results 21 to 30 of about 232,466 (85)

Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) Collies after oral administration

open access: yesParasites & Vectors, 2014
Background Fluralaner is a novel systemic ectoparasiticide for dogs providing long-acting flea- and tick-control after a single oral dose. This study investigated the safety of oral administration of fluralaner at 3 times the highest expected clinical ...
Feli M Walther   +4 more
doaj   +1 more source

Guidelines for the Use of Fluralaner ('Bravecto¬¨vÜ Spot-on Solution for Dogs‚ÄövÑv¥) to Treat Sarcoptic Mange in Wombats

open access: yes, 2021
This information sheet was prepared by the research team at the University of Tasmania, taking into account input from a range of stakeholders. Pending the issuing of an APVMA permit for Bravecto¬¨vÜ, the purpose of this sheet is to assist treaters and ...
Scott Carver (14733301)   +1 more
core  

A randomized, blinded, controlled USA field study to assess the use of fluralaner tablets in controlling canine flea infestations

open access: yesParasites & Vectors, 2014
Background The novel isoxazoline molecule fluralaner provides 12 weeks activity against fleas and 8 to 12 weeks against tick infestations according to label claims.
Cheyney Meadows   +2 more
doaj   +1 more source

Field efficacy of fluralaner (Bravecto® chewable tablets) for preventing Babesia canis infection transmitted by Dermacentor reticulatus ticks to dogs

open access: yes, 2023
The isoxazoline fluralaner is effective for prevention of Babesia canis transmission from infected Dermacentor reticulatus ticks to dogs for 84 days in a controlled environment. This study was designed to evaluate the effectiveness of fluralaner chewable
Capári, Balázs   +8 more
core   +2 more sources

Preventive efficacy of Bravecto Plus spot-on for cats (280mg/ml fluralaner and 14mg/ml moxidectin) against aelurostrongylosis in experimentally infected cats

open access: yes, 2020
Background: A negative-controlled, randomized, blinded laboratory study in 31 cats was carried out to evaluate the preventive efficacy of a topical parasiticide (Bravecto Plus spot-on solution for cats, MSD) against infections with the cat lungworm ...
Raue K   +5 more
core   +1 more source

Comparison of preference of oral fluralaner and afoxolaner by dogs in kaunas x animal shelter [PDF]

open access: yes, 2020
Oral medicines that have delicious (flavorful, palatable) properties for animals, mean that animal voluntarily take and ingest the product. Among them are the delicious chewable tablets with fluralaner (Bravecto) and afoxolaner (NexGard).
Dreskinienė, Skaistė
core  

Un/productive Raciality and Transnational Affiliations in Lydia Kwa’s Pulse [PDF]

open access: yes, 2016
This paper explores the intersections that develop as Canada and Singapore redefine the terms of their productive raciality through their respective multicultural/multiracial forms in order to remain globally competitive. It draws out these intersections
O’Brien, Michelle
core   +1 more source

COMMUNICATIVE ILLOCUTIONARY ACT ON STUDENTS’ CONVERSATION VIDEO IN ONE OF THE ENGLISH COURSES IN BANDUNG [PDF]

open access: yes, 2020
Speech acts are divided into three categories – locutionary, illocutionary, and perlocutionary. Each speech act can be investigated based on the researcher’s need what it is done in this research purpose of this study aiming to find out the context ...
Mu’man, Mu’man
core  

MUSABAQAH TAFSIRIL QUR’AN: A RELIGIOUS SCIENTIFIC CONTESTATION AND CEREMONIAL SYMBOL [PDF]

open access: yes, 2021
Artikel ini menjelaskan tentang pengalaman para peserta Musabaqah Tafsiril Qur’an (MTiQ) terutama yang berkaitan dengan motivasi, kompetensi dan manfaat mengikuti ajang kompetisi ini.
Rahtikawati, Yayan   +1 more
core  

Comparative efficacy of topical treatments with Revolution\u3csup\u3e®\u3c/sup\u3e Plus (selamectin and sarolaner) and Bravecto\u3csup\u3e®\u3c/sup\u3e for Cats (fluralaner) against Ixodes scapularis ticks on cats

open access: yes, 2019
The efficacy of three consecutive monthly treatments with a novel topical product (Revolution® Plus/Stronghold® Plus, Zoetis) containing selamectin in combination with the isoxazoline, sarolaner, was compared with that of another topical isoxazoline ...
King, Vickie L.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy